
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation
Mehreen Ghufran, Haider Ali Khan, Mehran Ullah, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4884-4884
Open Access | Times Cited: 23
Mehreen Ghufran, Haider Ali Khan, Mehran Ullah, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4884-4884
Open Access | Times Cited: 23
Showing 23 citing articles:
Targeting Peptides: The New Generation of Targeted Drug Delivery Systems
Biagio Todaro, Elisa Ottalagana, Stefano Luin, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1648-1648
Open Access | Times Cited: 32
Biagio Todaro, Elisa Ottalagana, Stefano Luin, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1648-1648
Open Access | Times Cited: 32
Leveraging Marine Predators Algorithm with Deep Learning for Lung and Colon Cancer Diagnosis
Hanan Abdullah Mengash, Mohammad Alamgeer, Mashael Maashi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1591-1591
Open Access | Times Cited: 29
Hanan Abdullah Mengash, Mohammad Alamgeer, Mashael Maashi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1591-1591
Open Access | Times Cited: 29
RAS‐targeted cancer therapy: Advances in drugging specific mutations
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18
In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression
Muhammad Shahab, Shahin Shah Khan, Maryam Zulfat, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Muhammad Shahab, Shahin Shah Khan, Maryam Zulfat, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
Mehreen Ghufran, Mehran Ullah, Haider Ali Khan, et al.
Bioengineering (2023) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 16
Mehreen Ghufran, Mehran Ullah, Haider Ali Khan, et al.
Bioengineering (2023) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 16
Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer
Abbas Khan, Yasir Waheed, Shilpa Kuttikrishnan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Abbas Khan, Yasir Waheed, Shilpa Kuttikrishnan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
Vimal H. Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Vimal H. Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Phyto-fabrication of ultrafine nanoscale holmium oxide HT-Ho2O3 NPs and their biomedical potential
Hamza Elsayed Ahmed Mohamed, Ali Talha Khalil, Khaoula Hkiri, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 27912-27922
Open Access | Times Cited: 11
Hamza Elsayed Ahmed Mohamed, Ali Talha Khalil, Khaoula Hkiri, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 27912-27922
Open Access | Times Cited: 11
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations
Muhammad Suleman, Tanveer Ahmad, Khadim shah, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Muhammad Suleman, Tanveer Ahmad, Khadim shah, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Unconventional strategy could be the future: From target to KRAS broad range treatment
Sara Fancelli, Giulia Petroni, Serena Pillozzi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29739-e29739
Open Access | Times Cited: 3
Sara Fancelli, Giulia Petroni, Serena Pillozzi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29739-e29739
Open Access | Times Cited: 3
Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against Brucellosis
Kanwal Khan, Munirah Sulaiman Othman Alhar, Muhammad Abbas, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 633-633
Open Access | Times Cited: 13
Kanwal Khan, Munirah Sulaiman Othman Alhar, Muhammad Abbas, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 633-633
Open Access | Times Cited: 13
Involvement of the Opioidergic Mechanism in the Analgesic Potential of a Novel Indazolone Derivative: Efficacy in the Management of Pain, Neuropathy, and Inflammation Using In Vivo and In Silico Approaches
Qarib Ullah, Zarshad Ali, Umer Rashid, et al.
ACS Omega (2023) Vol. 8, Iss. 25, pp. 22809-22819
Open Access | Times Cited: 7
Qarib Ullah, Zarshad Ali, Umer Rashid, et al.
ACS Omega (2023) Vol. 8, Iss. 25, pp. 22809-22819
Open Access | Times Cited: 7
Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker)
Yaseen Ur Rehman, Arshad Iqbal, Gowhar Ali, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yaseen Ur Rehman, Arshad Iqbal, Gowhar Ali, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
An extensive pharmacological evaluation of novel anti-nociceptive and IL-6 targeted anti-inflammatory guaiane-type sesquiterpenoids from Cinnamomum migao H. W. Li through in-depth in-vitro, ADMET, and molecular docking studies
Ishaq Muhammad, Syed Shams ul Hassan, Wenjing Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114946-114946
Open Access | Times Cited: 6
Ishaq Muhammad, Syed Shams ul Hassan, Wenjing Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114946-114946
Open Access | Times Cited: 6
Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer’s disease: molecular simulations-based predictions
Mater H. Mahnashi, Muhammad Ayaz, Mehreen Ghufran, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 4
Mater H. Mahnashi, Muhammad Ayaz, Mehreen Ghufran, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 4
In silico exploration of the potential inhibitory activities of in-house and ZINC database lead compounds against alpha-glucosidase using structure-based virtual screening and molecular dynamics simulation approach
Zuhier Awan, Haider Ali Khan, Alam Jamal, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access | Times Cited: 1
Zuhier Awan, Haider Ali Khan, Alam Jamal, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access | Times Cited: 1
Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
Muhammad Suleman, Abrar Mohammad Sayaf, Abbas Khan, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 7, pp. 102448-102448
Open Access | Times Cited: 1
Muhammad Suleman, Abrar Mohammad Sayaf, Abbas Khan, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 7, pp. 102448-102448
Open Access | Times Cited: 1
In Silico Targeting of Fascin Protein for Cancer Therapy: Benchmarking, Virtual Screening and Molecular Dynamics Approaches
Heba H. A. Hassan, Muhammad I. Ismail, Mohammed A. S. Abourehab, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1296-1296
Open Access | Times Cited: 3
Heba H. A. Hassan, Muhammad I. Ismail, Mohammed A. S. Abourehab, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1296-1296
Open Access | Times Cited: 3
The apoptotic and anti‐proliferative effects of Neosetophomone B in T‐cell acute lymphoblastic leukaemia via PI3K /AKT /mTOR pathway inhibition
Shilpa Kuttikrishnan, Abdul W. Ansari, Muhammad Suleman, et al.
Cell Proliferation (2024)
Open Access
Shilpa Kuttikrishnan, Abdul W. Ansari, Muhammad Suleman, et al.
Cell Proliferation (2024)
Open Access
Immunoinformatic based designing of highly immunogenic multi-epitope subunit vaccines to stimulate an adaptive immune response against Junin virus
Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, et al.
Molecular Diversity (2024)
Closed Access
Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, et al.
Molecular Diversity (2024)
Closed Access
Experimental Validation of MHC Class I and II Peptide-Based Potential Vaccine Candidates for Human Papilloma Virus Using Sprague-Dawly Models
Mehreen Ismail, Baogang Bai, Jinlei Guo, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1687-1687
Open Access | Times Cited: 1
Mehreen Ismail, Baogang Bai, Jinlei Guo, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1687-1687
Open Access | Times Cited: 1
Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
Ignacio Alfaro, Margarita Vega, Carmen Romero, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1515-1515
Open Access
Ignacio Alfaro, Margarita Vega, Carmen Romero, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1515-1515
Open Access
Silencing effects of mutant RAS signalling on transcriptomes
Christine Sers, Reinhold Schäfer
Advances in Biological Regulation (2022) Vol. 87, pp. 100936-100936
Closed Access
Christine Sers, Reinhold Schäfer
Advances in Biological Regulation (2022) Vol. 87, pp. 100936-100936
Closed Access